EU ‘Can’t Expect Industry To Give Up Proprietary Insights’ Under Health Data & Clinical Trials Regulations

 
• By Eliza Slawther
  
Companies will be concerned about giving up proprietary data under new EU health data sharing rules (Shutterstock)

More from Interviews

More from R&D